Genetic Variations of Drug Transporters Can Influence on Drug Response in Patients Treated with Docetaxel Chemotherapy
'
Genetic Variations of Drug Transporters Can Influence on Drug Response in Patients Treated with Docetaxel Chemotherapy' 의 주제별 논문영향력
| 주제 |
|
|
|---|---|---|
| 동일주제 총논문수 | 논문피인용 총횟수 | 주제별 논문영향력의 평균 |
| 1,347 | 0 |
0.0% |
주제별 논문영향력
' Genetic Variations of Drug Transporters Can Influence on Drug Response in Patients Treated with Docetaxel Chemotherapy' 의 참고문헌
-
The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions
-
The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions
-
The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients
-
The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients
-
Single nucleotide polymorphisms in ABCC2 and ABCB1 genes and their clinical impact in physiology and drug response
-
Single nucleotide polymorphisms in ABCC2 and ABCB1 genes and their clinical impact in physiology and drug response
-
Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs
-
Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs
-
Role of intestinal P-glycoprotein in the plasma and fecal disposition of docetaxel in humans
-
Role of intestinal P-glycoprotein in the plasma and fecal disposition of docetaxel in humans
-
Role of human cytochrome P450 3A4 and 3A5 in the metabolism of taxotere and its derivatives : enzyme specificity, interindividual distribution and metabolic contribution in human liver
-
Role of human cytochrome P450 3A4 and 3A5 in the metabolism of taxotere and its derivatives : enzyme specificity, interindividual distribution and metabolic contribution in human liver
-
Randomized phase II trial comparing carboplatin plus weekly paclitaxel and docetaxel alone in elderly patients with advanced non-small cell lung cancer : north japan lung cancer group trial 0801
-
Randomized phase II trial comparing carboplatin plus weekly paclitaxel and docetaxel alone in elderly patients with advanced non-small cell lung cancer : north japan lung cancer group trial 0801
-
Prediction of response to docetaxel by CYP3A4mRNA expression in breast cancer tissues
-
Prediction of response to docetaxel by CYP3A4mRNA expression in breast cancer tissues
-
Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects
-
Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects
-
Pharmacokinetics and toxicity of docetaxel : role of CYP3A, MDR1, and GST polymorphisms
-
Pharmacokinetics and toxicity of docetaxel : role of CYP3A, MDR1, and GST polymorphisms
-
Pharmacogenomics variation in drug metabolizing enzymes and transporters in relation to docetaxel toxicity in Lebanese breast cancer patients : paving the way for OMICs in low and middle income countries
-
Pharmacogenomics variation in drug metabolizing enzymes and transporters in relation to docetaxel toxicity in Lebanese breast cancer patients : paving the way for OMICs in low and middle income countries
-
Pharmacogenomics : drug disposition, drug targets, and side effects
-
Pharmacogenomics : drug disposition, drug targets, and side effects
-
Pharmacogenetic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxel
-
Pharmacogenetic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxel
-
Pharmacogenetic pathway analysis of docetaxel elimination
-
Pharmacogenetic pathway analysis of docetaxel elimination
-
Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients
-
Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients
-
Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel
-
Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel
-
Genetic contribution to variable human CYP3A-mediated metabolism
-
Genetic contribution to variable human CYP3A-mediated metabolism
-
Functional polymorphisms of the human multidrug-resistance gene : multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
-
Functional polymorphisms of the human multidrug-resistance gene : multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
-
Differences in CYP3A41G genotype distribution and haplotypes of CYP3A4, CYP3A5 and CYP3A7 in 3 Chinese populations
-
Differences in CYP3A41G genotype distribution and haplotypes of CYP3A4, CYP3A5 and CYP3A7 in 3 Chinese populations
-
Chemotherapy with modified docetaxel, cisplatin, and 5-fluorouracil in patients with metastatic head and neck cancer
-
Chemotherapy with modified docetaxel, cisplatin, and 5-fluorouracil in patients with metastatic head and neck cancer
-
Chemotherapy in elderly patients with advanced non-small cell lung cancer
-
Chemotherapy in elderly patients with advanced non-small cell lung cancer
-
CYP450 pharmacogenetics for personalizing cancer therapy
-
CYP450 pharmacogenetics for personalizing cancer therapy
-
Association study of genetic polymorphism in ABCC4 with cyclophosphamide-induced adverse drug reactions in breast cancer patients
-
Association study of genetic polymorphism in ABCC4 with cyclophosphamide-induced adverse drug reactions in breast cancer patients
-
Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia
-
Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia